Health Denali Therapeutics and Biogen Announce Initiation of Phase 2b Study of LRRK2 Inhibitor in Parkinson’s Disease May 31, 2022
Biotechnology argenx Announces the UK MHRA has Granted Early Access to Efgartigimod for Generalized Myasthenia Gravis May 31, 2022
Biotechnology AXSM LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Axsome Therapeutics, Inc. May 30, 2022
Biotechnology The Gross Law Firm Announces Class Actions on Behalf of Shareholders of LICY, BKKT and AXSM May 30, 2022
Tech Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Axsome, Humbl, Okta, and CareDx and Encourages Investors to Contact the Firm May 29, 2022
Biotechnology LAWSUITS FILED AGAINST ABBV, IIPR and AXSM – Jakubowitz Law Pursues Shareholders Claims May 27, 2022
Search
Biotechnology
